The NUAK1 inhibitor induces endoplasmic reticulum stress through the inhibition of the NRF2 antioxidant pathway, thereby triggering ICD of tumor cells and the release of DAMPs; e.g., CRT and ATP, DC—mediated antigen presentation. The gene discussed is NUAK1; the disease is neoplasm.